New to Meducation?
Sign up
Already signed up? Log In

Category

Preview
0
1

Doctors are under pressure from parents to postpone childhood vaccinations

The majority of doctors receive parental requests to alter childhood vaccination schedules. Despite having concerns, most doctors agree to such requests, according to new research.  
medicalnewstoday.com
almost 6 years ago
Preview
0
2

'Substandard vaccination' blamed for measles outbreak

In a research letter, experts state that suboptimal vaccination levels have impaired community immunity to the disease and put the greater population at risk.  
medicalnewstoday.com
almost 6 years ago
Preview
0
11

Swine Flu, Bird Flu And Pandemic Vaccination

As the world prepares for what may be the next pandemic strain of influenza virus, in the H7N9 bird flu, a new UC Irvine study reveals that the 2009 H1N1 swine flu pandemic was deadliest for...  
medicalnewstoday.com
almost 6 years ago
Preview
0
3

Bovine TB vaccinations and minimising 'false positives'

Bovine tuberculosis is a major economic disease of livestock worldwide. Despite an intensive, and costly, control program in the United Kingdom, bovine TB persists.  
medicalnewstoday.com
almost 6 years ago
Preview
0
3

Making a Strong Recommendation for Adult Vaccination

Learn how to strengthen vaccine recommendations for adult patients, including videos demonstrating quick and effective ways to share compelling information.  
medscape.com
almost 6 years ago
Preview
0
10

Cancer vaccines

Cancer vaccines are designed to promote tumor specific immune responses, particularly cytotoxic CD8 positive T cells that are specific to tumor antigens. The earliest vaccines, which were developed in 1994-95, tested non-mutated, shared tumor associated antigens that had been shown to be immunogenic and capable of inducing clinical responses in a minority of people with late stage cancer. Technological developments in the past few years have enabled the investigation of vaccines that target mutated antigens that are patient specific. Several platforms for cancer vaccination are being tested, including peptides, proteins, antigen presenting cells, tumor cells, and viral vectors. Standard of care treatments, such as surgery and ablation, chemotherapy, and radiotherapy, can also induce antitumor immunity, thereby having cancer vaccine effects. The monitoring of patients’ immune responses at baseline and after standard of care treatment is shedding light on immune biomarkers. Combination therapies are being tested in clinical trials and are likely to be the best approach to improving patient outcomes.  
feeds.bmj.com
almost 6 years ago
Preview
0
9

HPV vaccination for gay men

Stream HPV vaccination for gay men by BMJ talk medicine from desktop or your mobile device  
feeds.bmj.com
almost 6 years ago
Preview
0
8

STI podcast: Australia’s HPV vaccination programme and disappearing genital warts

Stream STI podcast: Australia’s HPV vaccination programme and disappearing genital warts by BMJ talk medicine from desktop or your mobile device  
feeds.bmj.com
almost 6 years ago
Preview
0
5

Pneumococcal vaccination for welders

Stream Pneumococcal vaccination for welders by BMJ talk medicine from desktop or your mobile device  
feeds.bmj.com
almost 6 years ago
Preview
0
14

Cancer vaccines

Cancer vaccines are designed to promote tumor specific immune responses, particularly cytotoxic CD8 positive T cells that are specific to tumor antigens. The earliest vaccines, which were developed in 1994-95, tested non-mutated, shared tumor associated antigens that had been shown to be immunogenic and capable of inducing clinical responses in a minority of people with late stage cancer. Technological developments in the past few years have enabled the investigation of vaccines that target mutated antigens that are patient specific. Several platforms for cancer vaccination are being tested, including peptides, proteins, antigen presenting cells, tumor cells, and viral vectors. Standard of care treatments, such as surgery and ablation, chemotherapy, and radiotherapy, can also induce antitumor immunity, thereby having cancer vaccine effects. The monitoring of patients’ immune responses at baseline and after standard of care treatment is shedding light on immune biomarkers. Combination therapies are being tested in clinical trials and are likely to be the best approach to improving patient outcomes.  
feeds.bmj.com
almost 6 years ago
Preview
0
14

Haemophilus influenzae type B and viral influenza vaccinations during pregnancy for improving maternal, neonatal and infant health outcomes | Cochrane

Maternal immunisation with Haemophilus influenzae type B (Hib) and viral influenza vaccines may reduce the risk of infections in mothers and infants, however, this is an area of controversy. Both infections can cause severe pneumonia and deaths among children under five years of age, particularly in developing countries. Rates of influenza-associated complications and consequent hospitalisations are substantially higher among pregnant women, infants and newborns. Pregnant women who are vaccinated against influenza have protective levels of anti-influenza antibodies, which can be passively transferred to the infant to improve their health outcomes. Infants of immune mothers usually have influenza symptoms that are delayed in onset and of shorter duration. This review investigated whether vaccinating pregnant women with Hib and viral influenza vaccinations during pregnancy could reduce the risk of infection among mothers and babies and improve health outcomes for both.  
cochrane.org
over 5 years ago
Www.bmj
0
4

One dose of HPV vaccine could prevent most cervical cancers, studies show

One dose of bivalent human papillomavirus (HPV) vaccine may be adequate to prevent most cases of cervical cancer, shows a study combining data from two large trials and published in Lancet Oncology1 that found similar protection against HPV infection from a single vaccination as from the current two and three dose schedules.  
feeds.bmj.com
over 5 years ago
Www.bmj
0
6

UK vaccine damage scheme must pay £120 000 to boy who developed narcolepsy after swine flu vaccination

A 12 year old boy who developed narcolepsy and cataplexy after being vaccinated against swine flu at age 7 has been awarded £120 000 (€165 000; $186 000) in compensation, in a ruling that opens the way for dozens of similar awards from the United Kingdom’s statutory vaccine damage compensation scheme.  
feeds.bmj.com
over 5 years ago
Www.bmj
0
3

UK vaccine damage scheme must pay £120 000 to boy who developed narcolepsy after swine flu vaccination

A 12 year old boy who developed narcolepsy and cataplexy after being vaccinated against swine flu at age 7 has been awarded £120 000 (€165 000; $186 000) in compensation, in a ruling that opens the way for dozens of similar awards from the United Kingdom’s statutory vaccine damage compensation scheme.  
feeds.bmj.com
over 5 years ago
Www.bmj
0
6

UK vaccine damage scheme must pay £120 000 to boy who developed narcolepsy after swine flu vaccination

A 12 year old boy who developed narcolepsy and cataplexy after being vaccinated against swine flu at age 7 has been awarded £120 000 (€165 000; $186 000) in compensation, in a ruling that opens the way for dozens of similar awards from the United Kingdom’s statutory vaccine damage compensation scheme.  
feeds.bmj.com
over 5 years ago